HOMEPRODUCTSCOMPANYCONTACTFAQResearchDictionaryPharmaSign Up FREE or Login

Knock-down of LAR protein tyrosine phosphatase induces insulin resistance.

Abstract
To test the role of the leukocyte common antigen-related protein tyrosine phosphatase (LAR) as a regulator of insulin receptor (IR) signalling, an siRNA probe against LAR was developed. Knock-down of LAR induced post-receptor insulin resistance with the insulin-induced activation of PKB/Akt and MAP kinases markedly inhibited. The phosphorylation and dephosphorylation of the IR and insulin receptor substrate (IRS) proteins were unaffected by LAR knock-down. These results identify LAR as a crucial regulator of the sensitivity of two key insulin signalling pathways to insulin. Moreover, the siRNA probe provides a molecular tool of general applicability for further dissecting the precise targets and roles of LAR.
AuthorsAnn Mander, Conrad P Hodgkinson, Graham J Sale
JournalFEBS letters (FEBS Lett) Vol. 579 Issue 14 Pg. 3024-8 (Jun 06 2005) ISSN: 0014-5793 [Print] England
PMID15896785 (Publication Type: Journal Article, Research Support, Non-U.S. Gov't)
Chemical References
  • Insulin
  • RNA, Small Interfering
  • Receptors, Cell Surface
  • Phosphotyrosine
  • Receptor, Insulin
  • PTPRA protein, human
  • Protein Tyrosine Phosphatases
  • Receptor-Like Protein Tyrosine Phosphatases, Class 4
Topics
  • Cell Line
  • Humans
  • Insulin (pharmacology)
  • Insulin Resistance (genetics)
  • Phosphotyrosine (metabolism)
  • Protein Tyrosine Phosphatases (deficiency, genetics, metabolism)
  • RNA, Small Interfering (genetics, metabolism)
  • Receptor, Insulin (metabolism)
  • Receptor-Like Protein Tyrosine Phosphatases, Class 4
  • Receptors, Cell Surface (deficiency, genetics, metabolism)
  • Signal Transduction (drug effects)
  • Substrate Specificity

Join CureHunter, for free Research Interface BASIC access!

Take advantage of free CureHunter research engine access to explore the best drug and treatment options for any disease. Find out why thousands of doctors, pharma researchers and patient activists around the world use CureHunter every day.
Realize the full power of the drug-disease research graph!


Choose Username:
Email:
Password:
Verify Password:
Enter Code Shown: